Huons Global surpassed 500 billion won in sales last year… The greatest performance ever

[서울=뉴스핌] Reporter Park Da-young = Huons Global recorded the highest performance ever, surpassing 500 billion won in sales thanks to an increase in demand for botulinum toxins despite the novel coronavirus infection (Corona 19) epidemic.

Huons Global announced on the 15th that operating profit based on consolidated financial statements last year was 89.2 billion won, a 22% increase from the previous year. Sales increased by 16% to 523 billion won.

[로고=휴온스글로벌]

Huons Global surpassed 500 billion won in one year after reaching 400 billion won in annual sales for the first time in 2019.

Even as of the single quarter, the fourth quarter, it achieved the highest quarterly performance ever. Based on consolidated financial statements, sales increased 16% year-on-year to 143 billion won, and operating profit increased 22% to 24.3 billion won.

An official of Huons Global analyzed that “the growth was led by increasing demand for botulinum toxins (Liztox, Hutox, etc.) and the operation of the second plant in earnest.”

Subsidiaries also continued to grow. As of last year, Huons recorded 406.7 billion won in sales and 54.1 billion won in operating profit, and continued double-digit growth of 11% and 12%, respectively, compared to the previous year. Humedix broke the record for the highest performance ever thanks to stable growth in the aesthetics business and robust exports of Corona 19 diagnostic kits.

Due to Corona 19, Huons Medicare’s exports of infection control products and eye drops and other specialty drug businesses have advanced. Sales increased by 11% to 38.9 billion won and operating profit of 7.1 billion won. Huvena, a medical container company, increased both sales and operating profit due to the growth of medical glass containers, scientific instruments, and laboratory containers.

Yoon Seong-tae, vice chairman of Huons Global, said, “Huons Group will create good results this year by continuing the stance of flexible thinking, flexible management, preemptive investment and market response to respond to uncertainties.”

[email protected]

Source